Fluoroquinolone prescribing in the United States: 1995 to 2002.
about
Excessive antibiotic use in men with prostatitisUnnecessary use of fluoroquinolone antibiotics in hospitalized patientsAntimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile InfectionTrends in antibiotic prescribing in adults in Dutch general practiceGender analysis of moxifloxacin clinical trialsEarly postoperative fluoroquinolone use is associated with an increased revision rate after arthroscopic rotator cuff repair.Fluoroquinolones in the management of community-acquired pneumonia in primary care.Antibiotic use for Vibrio infections: important insights from surveillance dataIncreased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.Assessing sensitivity to antibacterial topoisomerase II inhibitors.Antibiotic precautions in athletesRisk of retinal tear or detachment with oral fluoroquinolone use: a cohort studyGastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance.Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patientsEmergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones.Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infectionsIndependent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.Tendon Injury and Fluoroquinolone Use: A Systematic Review.Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.Antibiotic resistance in uropathogenic e. Coli strains isolated from non-hospitalized patients in pakistan.New real-time PCR assay using locked nucleic acid probes to assess prevalence of ParC mutations in fluoroquinolone-susceptible Streptococcus pneumoniae isolates from France.Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States.Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort studyUpgrading antibiotic use within a class: tradeoff between resistance and treatment success.Plasmid-mediated quinolone resistance.Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?Clostridium difficile in the Long-Term Care Facility: Prevention and ManagementPrevalence and fluoroquinolone resistance of pseudomonas aeruginosa in a hospital of South China.Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong.Prioritizing future research on off-label prescribing: results of a quantitative evaluationEvaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia.Deoxynybomycins inhibit mutant DNA gyrase and rescue mice infected with fluoroquinolone-resistant bacteriaActivity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions.Respiratory fluoroquinolone use and influenzaFluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, CanadaPermanent Peripheral Neuropathy: A Case Report on a Rare but Serious Debilitating Side-Effect of Fluoroquinolone Administration.Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States
P2860
Q24646502-EABD4A54-4E13-4E5C-AFAA-22D9CA96F105Q27496669-D4FBC4E5-B4D1-4018-95FC-5F3EE6BB054FQ28084026-094AFC54-345C-4B16-AE42-3D17F31AD787Q28484302-D4778B52-726F-4134-9758-E2DCF799C09FQ28538319-F6DD124E-49D5-4B23-B505-C8216C4FB3A3Q30275742-5E27EAD9-EA98-4C12-AA23-C377C5A62AB7Q30452249-CB37DDA8-3A90-47EC-8BA7-0D002FC385F9Q30969459-EC36F60E-7FC6-4D03-BE18-B8AD090A9FE0Q33314977-4687FDF0-9617-4197-8CF2-AEC243E84580Q33771873-797B1F3E-1028-4E88-931F-D17584A183D1Q33786181-26B74402-2503-446D-BBDB-29F340F00AD0Q33889295-D5331E04-7B7F-4E1F-A84C-B83CFC1B5060Q33905604-093B5D01-735E-422E-AD6F-97AC1212203EQ33945413-2D59AA79-8C95-4096-8BC4-980F58847E15Q33964949-1C41C194-D7AD-4130-A9BE-1D2E806D449FQ33990521-5450BFFC-E12B-42B5-9A16-DE960DADF241Q34058190-A3F49942-547D-4A62-83D1-5B43504F86F6Q34233075-E39495C5-F0B9-4244-9184-4E16520991C3Q34309613-9DA1F033-1291-4C3A-8773-5457E9B47EA5Q34359994-307EB4EA-F542-4CE2-B8ED-F3D2EB539CA2Q34384649-5418C224-BF3D-40AB-9465-08D82C5C9A28Q34479623-A41A2069-AE97-474B-AC57-07DA7974A59AQ34510372-F2AC2912-F47F-4D10-99FF-89594FAD1287Q34609380-12CF9178-9CDF-4467-A625-29AFBD29FCDAQ34641587-C48A8826-41EA-4F9D-8193-DD4457FC9FDDQ34674473-E5FA9FF1-EE1C-424B-82D5-C987E95DB00DQ34687139-04FDF85A-74FB-4704-A0F9-7B1611FBB265Q34888920-2CD2E0A6-7185-4797-B937-BEF2E94F67C6Q35023239-1D0C51B3-3DAB-4B23-9AA1-38CA980B5D9BQ35065783-84D649BE-08F4-4280-AC0B-13D64F326739Q35173914-A1488DF6-BC46-4CC9-940C-D7297B4E028CQ35317777-18270A59-AA6A-4594-A2F7-C60A84E762BAQ35525794-C870DDEE-9CA5-41BE-AFD9-6E5E6DA8B702Q35541906-7AE1C317-7B01-48BA-A01C-5659F88CBE48Q35574888-C2AE770E-6550-405E-8C68-D9182AFC03AAQ35592636-19761061-0F9D-4149-BFA4-78CC781F2C63Q35673288-19B5B87A-223A-4701-A5A0-801AB6CCEBBAQ35805806-E2CECABC-2579-49ED-93E4-73D362A198E2Q35927711-39F4AE46-0331-44CA-8981-7E7B2874A53DQ36147980-7DB281A4-CE59-49A5-8F9B-7775BA0C2432
P2860
Fluoroquinolone prescribing in the United States: 1995 to 2002.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@ast
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@en
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@nl
type
label
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@ast
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@en
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@nl
prefLabel
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@ast
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@en
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@nl
P2093
P1476
Fluoroquinolone prescribing in the United States: 1995 to 2002.
@en
P2093
Elbert S Huang
Jeffrey A Linder
Michael A Steinman
Ralph Gonzales
Randall S Stafford
P304
P356
10.1016/J.AMJMED.2004.09.015
P407
P577
2005-03-01T00:00:00Z